| Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase … R Fleischmann, E Mysler, S Hall, AJ Kivitz, RJ Moots, Z Luo, R DeMasi, ... The Lancet 390 (10093), 457-468, 2017 | 481 | 2017 |
| Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy KY Choi, HY Yoon, JH Kim, SM Bae, RW Park, YM Kang, IS Kim, IC Kwon, ... ACS nano 5 (11), 8591-8599, 2011 | 424 | 2011 |
| High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry C Sun, JE Molineros, LL Looger, X Zhou, K Kim, Y Okada, J Ma, Y Qi, ... Nature genetics 48 (3), 323-330, 2016 | 233 | 2016 |
| CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis YM Kang, X Zhang, UG Wagner, H Yang, RD Beckenbaugh, PJ Kurtin, ... The Journal of experimental medicine 195 (10), 1325-1336, 2002 | 228 | 2002 |
| Genome‐wide association study of rheumatoid arthritis in Koreans: population‐specific loci as well as overlap with European susceptibility loci J Freudenberg, HS Lee, BG Han, HD Shin, YM Kang, YK Sung, SC Shim, ... Arthritis & Rheumatism 63 (4), 884-893, 2011 | 181 | 2011 |
| Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer SJ Lee, SY Lee, HS Jeon, SH Park, JS Jang, GY Lee, JW Son, CH Kim, ... Cancer Epidemiology Biomarkers & Prevention 14 (3), 571-575, 2005 | 177 | 2005 |
| In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery VG Deepagan, S Kwon, DG You, W Um, H Ko, H Lee, DG Jo, YM Kang, ... Biomaterials 103, 56-66, 2016 | 175 | 2016 |
| Polymorphisms in the survivin gene and the risk of lung cancer JS Jang, KM Kim, KH Kang, JE Choi, WK Lee, CH Kim, YM Kang, S Kam, ... Lung cancer 60 (1), 31-39, 2008 | 171 | 2008 |
| DNMT3B polymorphisms and risk of primary lung cancer SJ Lee, HS Jeon, JS Jang, SH Park, GY Lee, BH Lee, CH Kim, YM Kang, ... Carcinogenesis 26 (2), 403-409, 2005 | 167 | 2005 |
| Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis R Heo, DG You, W Um, KY Choi, S Jeon, JS Park, Y Choi, S Kwon, K Kim, ... Biomaterials 131, 15-26, 2017 | 151 | 2017 |
| VEGF gene polymorphisms and susceptibility to rheumatoid arthritis SW Han, GW Kim, JS Seo, SJ Kim, KH Sa, JY Park, J Lee, SY Kim, ... Rheumatology 43 (9), 1173-1177, 2004 | 148 | 2004 |
| Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease YJ Lee, Y Horie, GR Wallace, YS Choi, JA Park, JY Choi, R Song, ... Annals of the rheumatic diseases 72 (9), 1510-1516, 2013 | 139 | 2013 |
| High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci K Kim, SY Bang, HS Lee, SK Cho, CB Choi, YK Sung, TH Kim, JB Jun, ... Annals of the rheumatic diseases 74 (3), e13-e13, 2015 | 134 | 2015 |
| Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery HS Han, T Thambi, KY Choi, S Son, H Ko, MC Lee, DG Jo, YS Chae, ... Biomacromolecules 16 (2), 447-456, 2015 | 133 | 2015 |
| Caspase 9 promoter polymorphisms and risk of primary lung cancer JY Park, JM Park, JS Jang, JE Choi, KM Kim, SI Cha, CH Kim, YM Kang, ... Human molecular genetics 15 (12), 1963-1971, 2006 | 130 | 2006 |
| Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma JH Han, Y Kang, HC Shin, HS Kim, YM Kang, YB Kim, SY Oh Archives of pathology & laboratory medicine 127 (10), 1330-1334, 2003 | 130 | 2003 |
| Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis YW Park, YM Kang, J Butterfield, M Detmar, JJ Goronzy, CM Weyand The American journal of pathology 165 (6), 2087-2098, 2004 | 120 | 2004 |
| Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus X Yin, K Kim, H Suetsugu, SY Bang, L Wen, M Koido, E Ha, L Liu, ... Annals of the rheumatic diseases 80 (5), 632-640, 2021 | 114 | 2021 |
| Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy MJ Kim, JS Park, SJ Lee, J Jang, JS Park, SH Back, G Bahn, JH Park, ... Journal of Controlled Release 216, 140-148, 2015 | 112 | 2015 |
| Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis E Davila, YM Kang, YW Park, H Sawai, X He, S Pryshchep, JJ Goronzy, ... The Journal of Immunology 174 (11), 7292-7301, 2005 | 103 | 2005 |
